World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
120
Citations
65925
World Ranking
3695
National Ranking
2035

Jay H. Ryu publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Jay H. Ryu sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 630 publications — 75th percentile

75% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Jay H. Ryu D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Jay H. Ryu sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 120 D-Index — 82nd percentile

82% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Jay H. Ryu is affiliated with the Mayo Clinic in the United States and specializes in medicine, with a strong research focus in pulmonary and respiratory medicine. Their work spans 427 publications in medicine, including significant contributions to subfields such as pulmonary and respiratory medicine, physiology, epidemiology, surgery, and rheumatology.

The main topics of Jay H. Ryu's research include:

  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Histiocytic Disorders and Treatments
  • Sarcoidosis and Beryllium Toxicity Research
  • Medical Imaging and Pathology Studies
  • Eosinophilic Disorders and Syndromes
  • Occupational and Environmental Lung Diseases
  • Neuroendocrine Tumor Research Advances

Jay H. Ryu has coauthored extensively with several researchers, including:

  • Robert Vassallo
  • Ronald S. Go
  • Matthew J. Koster
  • Karen L. Rech
  • Aishwarya Ravindran

Their frequent publication venues highlight a strong presence in respiratory and biomedical literature:

  • CHEST Journal
  • Faculty Opinions - Post-Publication Peer Review of the Biomedical Literature
  • Blood
  • Respiratory Medicine
  • Orphanet Journal of Rare Diseases

Notable recent papers by Jay H. Ryu include:

  • Diagnosis and Evaluation of Hypersensitivity Pneumonitis, 2021, CHEST Journal
  • Methotrexate and Rheumatoid Arthritis Associated Interstitial Lung Disease, 2020, European Respiratory Journal
  • Chest CT Diagnosis and Clinical Management of Drug-Related Pneumonitis in Patients Receiving Molecular Targeting Agents and Immune Checkpoint Inhibitors, 2021, CHEST Journal
  • Managing Chronic Cough as a Symptom in Children and Management Algorithms, 2020, CHEST Journal
  • Chest CT Diagnosis and Clinical Management of Drug-related Pneumonitis in Patients Receiving Molecular Targeting Agents and Immune Checkpoint Inhibitors: A Position Paper from the Fleischner Society, 2021, Radiology

Best Publications

  • An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-Based Guidelines for Diagnosis and Management

    Ganesh Raghu;Harold R. Collard;Jim J. Egan;Fernando J. Martinez

  • American thoracic society/European respiratory society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias

    William D. Travis;Talmadge E. King;Eric D. Bateman;David A. Lynch

  • An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias

    William D. Travis;Ulrich Costabel;David M. Hansell;Talmadge E. King

  • Prognostic Significance of Histopathologic Subsets in Idiopathic Pulmonary Fibrosis

    Julie A. Bjoraker;Jay H. Ryu;Mark K. Edwin;Jeffrey L. Myers

  • Acute Exacerbations of Idiopathic Pulmonary Fibrosis

    Harold R. Collard;Bethany B. Moore;Kevin R. Flaherty;Kevin K. Brown

  • A Multidimensional Index and Staging System for Idiopathic Pulmonary Fibrosis

    Brett Ley;Christopher J. Ryerson;Eric Vittinghoff;Jay H. Ryu

  • International Consensus Guidance Statement on the Management and Treatment of IgG4-Related Disease

    A. Khosroshahi;Z. S. Wallace;J. L. Crowe;T. Akamizu

  • Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White Paper.

    David A Lynch;Nicola Sverzellati;William D Travis;Kevin K Brown

  • Incidence and mortality of interstitial lung disease in rheumatoid arthritis: A population-based study

    Tim Bongartz;Carlotta Nannini;Yimy F. Medina-Velasquez;Sara J. Achenbach

  • Polymyositis-dermatomyositis-associated interstitial lung disease.

    William W. Douglas;Henry D. Tazelaar;Thomas E. Hartman;Robert P. Hartman

  • Pulmonary Langerhans'-cell histiocytosis.

    Robert Vassallo;Jay H. Ryu;Thomas V. Colby;Thomas Hartman

  • Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease

    E. J. Kim;B. M. Elicker;F. Maldonado;W. R. Webb

  • Lymphangioleiomyomatosis. Clinical course in 32 patients.

    J R Taylor;J Ryu;T V Colby;T A Raffin

  • The NHLBI lymphangioleiomyomatosis registry: characteristics of 230 patients at enrollment.

    Jay H. Ryu;Joel Moss;Gerald J. Beck;Jar Chi Lee

  • Incidence, Prevalence, and Clinical Course of Idiopathic Pulmonary Fibrosis: A Population-Based Study

    Evans R. Fernández Pérez;Craig E. Daniels;Darrell R. Schroeder;Jennifer St. Sauver

  • Clinical outcomes of pulmonary Langerhans'-cell histiocytosis in adults.

    Robert Vassallo;Jay H. Ryu;Darrell R. Schroeder;Paul A. Decker

  • Gastroesophageal reflux therapy is associated with longer survival in patients with idiopathic pulmonary fibrosis.

    Joyce S. Lee;Jay H. Ryu;Brett M. Elicker;Carmen P. Lydell

  • Pulmonary Hypertension in Patients With Idiopathic Pulmonary Fibrosis

    Hassan F. Nadrous;Patricia A. Pellikka;Michael J. Krowka;Karen L. Swanson

  • Etiology of Chylothorax in 203 Patients

    Clinton H. Doerr;Mark S. Allen;Francis C. Nichols;Jay H. Ryu

  • Interstitial lung disease in primary Sjögren syndrome.

    Joseph G. Parambil;Jeffrey L. Myers;Rebecca M. Lindell;Eric L. Matteson

Frequent Co-Authors

Thomas V. Colby
Thomas V. Colby Mayo Clinic
Eric L. Matteson
Eric L. Matteson Mayo Clinic
Harold R. Collard
Harold R. Collard University of California, San Francisco
Kevin K. Brown
Kevin K. Brown National Jewish Health
Talmadge E. King
Talmadge E. King University of California, San Francisco
Athol U. Wells
Athol U. Wells Imperial College London
Andrew H. Limper
Andrew H. Limper Mayo Clinic
Susan M. Tarlo
Susan M. Tarlo University of Toronto
Christopher E. Brightling
Christopher E. Brightling University of Leicester

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

The healthcare field in the USA offers a wide range of online degree programs and certifications that can open doors to fulfilling careers. For those interested in health data and systems, online mhi programs (Master of Health Informatics) provide the skills needed to manage and analyze patient information effectively.

Another in-demand path is medical coding certification online. This short-term credential prepares graduates for a role in maintaining and processing healthcare records—a growing profession with remote work potential.

If you are drawn to direct patient care, consider exploring the cheapest fnp programs online. Becoming a Family Nurse Practitioner (FNP) can be a flexible and cost-effective way to advance your nursing career.

For many, a basic nursing degree is the first step. Wondering how much is online nursing school? Program costs can vary widely, but several affordable options make nursing education attainable and convenient through online study.

Best Scientists Citing Jay H. Ryu

Trending Scientists

Recently Published Articles